Sono-Tek to Present at Spartan Capital Investor Conference, Highlighting Growth in Ultrasonic Coating Technology
Sono-Tek Corporation will present at Spartan Capital Securities' Second Annual Investor Conference, showcasing the company's expanding role in developing ultrasonic coating systems for medical devices, semiconductors, and clean energy applications.
Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, will present at Spartan Capital Securities' Second Annual Investor Conference on November 3, 2025, at the Marriott Marquis Hotel in New York City. The company's participation underscores the conference's mission to spotlight innovative companies positioned for long-term growth across multiple high-value sectors.
"We are honored to be invited to share the Sono-Tek growth story with such a distinguished audience of investors and peers," said Steve Harshbarger, CEO & President of Sono-Tek. "The Spartan Capital Conference offers a unique platform to highlight our progress and connect with existing and new investors." The conference will showcase more than 60 carefully selected companies across technology, healthcare, consumer, mining, precious metals, and other high-growth sectors, with over 500 institutional and high-net-worth investors expected to attend.
Sono-Tek's presentation gains significance given the company's expanding role in multiple critical industries. The company's ultrasonic coating systems apply thin films onto parts in diverse sectors including medical devices, semiconductors, microelectronics, alternative energy, and advanced industrial manufacturing. This technological versatility positions Sono-Tek at the intersection of several high-growth markets, from life-saving medical technologies to next-generation semiconductor manufacturing.
John D. Lowry, Founder and Chief Executive Officer of Spartan Capital Securities, LLC, stated, "We are delighted to feature Sono-Tek at our second annual investor conference. Spartan Capital has built its reputation on helping growth companies access the right investors and resources, and this conference is a powerful extension of that mission - bringing together high-quality companies and serious investors under one roof." The event will feature main-stage presentations, expert panels, curated one-on-one meetings, and extensive networking sessions, creating meaningful opportunities for dialogue between growth companies and the investment community.
The company's growth trajectory reflects its transition from research and development tools to high-volume production machines with significantly higher average selling prices. Sono-Tek's medical device applications include precision coatings for life-saving technologies such as stents, balloons, diagnostic devices, and various drug delivery platforms. Simultaneously, the company's semiconductor and microelectronics applications continue to expand as customers increasingly turn to Sono-Tek for solutions supporting next-generation chips, displays, and sensors.
Sono-Tek's technologies are also advancing clean energy applications, including coatings for fuel cells, carbon capture, advanced solar cells, and various other advanced industrial applications. This broad market reach demonstrates the versatility of Sono-Tek's ultrasonic coating platforms and their relevance across multiple transformative industries. For more information about the conference and registration details, please visit Spartan Capital Investor Conference 2025 Registration.